Pulmatrix (PULM) Return on Sales (2014 - 2024)
Pulmatrix (PULM) posted Return on Sales of 6.26% for Q4 2024, down 8785.19% sequentially from 0.07% in Q3 2024, and down 625.0% YoY from 1.19% in Q1 2024.
Pulmatrix (PULM) Return on Sales (2014 - 2024) Analysis & Trends
Pulmatrix has reported Return on Sales for 11 years, with the latest figure at 6.26% in Q4 2024.
- Quarterly Return on Sales fell 625.0% year-over-year to 6.26% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.03% (down 1.0% YoY) and the FY2024 annual result came in at 0.01%, up 4.0% from the prior year.
- Return on Sales slipped to 6.26% in Q4 2024 per PULM's latest filing, from 0.07% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q3 2020 and troughed at 6.26% in Q4 2024.
- A 5-year average of 0.35% and a median of 0.03% in 2021 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2022 and 2024: Return on Sales grew 7 bps in 2022, then tumbled 625 bps in 2024.
- Over 5 years, Return on Sales stood at 0.01% in 2020, then slumped by 597 bps to 0.1% in 2021, then surged by 71 bps to 0.03% in 2022, then jumped by 65 bps to 0.01% in 2023, then sank by 65048 bps to 6.26% in 2024.
- According to Business Quant data, Return on Sales over the past three periods registered 6.26%, 0.07%, and 0.04% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Pulmatrix | 5.66 Mn | 5.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -6.26% |
| Sep 30, 2024 | -0.07% |
| Jun 30, 2024 | -0.04% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.04% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | -0.10% |
| Sep 30, 2021 | -0.08% |
| Jun 30, 2021 | -0.02% |
| Mar 31, 2021 | -0.03% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | -0.01% |
| Mar 31, 2020 | -0.02% |